Home » Glaxo, Novartis to Get U.S. Contracts to Make Vaccines
Glaxo, Novartis to Get U.S. Contracts to Make Vaccines
Pharmaceutical companies including GlaxoSmithKline and Novartis AG will get federal money to help develop medicines against pandemics and bioterrorist threats, the U.S. government said.
Reuters
Reuters
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May